FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives FDA takes first step in possible reversal of ban on some peptides The Washington Post Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law fda warning bpc 157 peptide products New Details 157 Unapproved peptides are now being sold by the world's largest online retailers, despite many appearing on the WADA Prohibited List and not legal for human consumption. Products like BPC 157, AOD 9604,